The 2024 Nobel Prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun “for the discovery of microRNA and its role in post-transcriptional gene regulation.”
The prize recognizes the “discovery of a fundamental principle governing how gene activity is regulated,” the Nobel Assembly at the Karolinska Institute in Sweden said October 7 in a press release.
Ambros, of the University of Massachusetts Chan Medical School in Worcester, and Ruvkun, of Harvard Medical School, will split the prize of 11 million Swedish kroner, or about $1 million.
This is a developing story that will be updated later today.